Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study)

Blood (2020) 136 (Supplement 1): 42.

https://doi.org/10.1182/blood-2020-140032

Published: 2020

Journal Articles

BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC"

Sara Di Giusto, PhD, Eleonora Toffoletti, MD, Massimiliano Bonifacio, MD, Gianni Binotto, MD, Maria Cristina Miggiano, MD, Elisabetta Calistri, MD, Manuela Stulle, MD, Anna Ermacora, MD, Rossella Stella, MD, Luigi Scaffidi, MD, Fabio D'Amore, MD, Giorgia Scotton, MD, Giovanna De Matteis, PhD, Roberta Bertorelle, PhD, Renato Fanin, MD, Mauro Krampera, MD PhD, Gianpietro Semenzato, MD, Daniela Damiani, MD, Mario Tiribelli, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-135968

Published: 2020

Journal Articles

ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients

Mario Tiribelli, MD, Sara Di Giusto, Eleonora Toffoletti, Davide Griguolo, Domenico Penna, Giorgia Maccari, Marta Medeot, Renato Fanin, Daniela Damiani

Blood (2017) 130 (Supplement 1): 1614.

https://doi.org/10.1182/blood.V130.Suppl_1.1614.1614

Published: 2017

Journal Articles

Clinical Factors Predictive Of Myelofibrotic Evolutions In Patients With Essential Thrombocythemia and Polycythemia Vera

Mario Tiribelli, MD, Federico De Marchi, MD, Daniela Barraco, MD, Luciana Marin, MD, Erika Codarin, PhD, Silvia Buttignol, MD, Daniela Damiani, MD, Renato Fanin, MD

Blood (2013) 122 (21): 4082.

https://doi.org/10.1182/blood.V122.21.4082.4082

Published: 2013

Journal Articles

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Blood (2010) 116 (21): 967.

https://doi.org/10.1182/blood.V116.21.967.967

Published: 2010

Journal Articles

A Simple Clinical Prognostic Scoring System for Newly Diagnosed Cytogenetically Normal Acute Myeloid Leukemia: a Retrospective Analysis on 530 Patients

Blood (2010) 116 (21): 4848.

https://doi.org/10.1182/blood.V116.21.4848.4848

Published: 2010

Journal Articles

Q141K Polymorphism of ABCG2 Protein Is Associated with Poor Prognosis In Adult Acute Myeloid Leukemia Treated with a Idarubicin-Based Chemotherapy Protocol

Daniela Damiani, Mario Tiribelli, Angela Michelutti, Dora Fabbro, Alessandra Franzoni, Margherita Cavallin, Antonella Geromin, Eleonora Toffoletti, Annalisa Pianta, Roberto Gallina, Giuseppe Damante, Renato Fanin

Blood (2010) 116 (21): 4941.

https://doi.org/10.1182/blood.V116.21.4941.4941

Published: 2010

Journal Articles

Gemtuzumab-Ozogamicin in Combination with Fludarabine, Cytarabine, Idarubicin (FLAI-GO) as Induction Therapy in CD33-Positive AML patients Younger Than 65 Years. Report of a Multicentric Trial

Blood (2008) 112 (11): 3998.

https://doi.org/10.1182/blood.V112.11.3998.3998

Published: 2008

Journal Articles

Brain Natriuretic Peptide (BNP) Level as Marker of Cardiac Function in Imatinib - Treated Chronic Myeloid Leukemia Patients: No Evidence of Cardiotoxicity of Imatinib Therapy.

Mario Tiribelli, MD, Antonio Colatutto, MD, Luciana Marin, MD, Eleonora Toffoletti, MD, Giuseppe Barbina, PhD, Ugo Qualizza, MD, Elio Tonutti, MD, Anna Candoni, MD, Marta Medeot, MD, Daniela Damiani, MD, Giorgio Morocutti, MD, Sala Pierguido, MD, Renato Fanin, MD

Blood (2007) 110 (11): 2948.

https://doi.org/10.1182/blood.V110.11.2948.2948

Published: 2007

Journal Articles

Fungal and Bacterial Infections in Acute Myeloid Leukemia Patients Treated with Induction Regimens Including Fludarabine: A Retrospective Analysis of 224 Cases.

Blood (2007) 110 (11): 4351.

https://doi.org/10.1182/blood.V110.11.4351.4351

Published: 2007

Journal Articles

Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow)

Blood (2007) 110 (9): 3438–3446.

https://doi.org/10.1182/blood-2006-11-055566

Published: 2007

Includes: Multimedia, Supplemental data

Journal Articles

Fludarabine Based Regimen (FLAI) Is an Effective Treatment for Induction of Multidrug Resistant Pgp-Positive Acute Myeloid Leukemia Patients.

Blood (2005) 106 (11): 1857.

https://doi.org/10.1182/blood.V106.11.1857.1857

Published: 2005

Journal Articles

Antiproliferative Effects of Tyrosine Kinase (STI 571) and Farnesyl Transferase Inhibitors (R115777 and SCH66336) on Acute Leukemia Human Tumor Cell Lines.

Domenico Russo, MD, Angela Michelutti, MD, Michele Malagola, MD, Tiziana Grafone, MD, Emanuela Ottaviani, MD, Anna Candoni, MD, Cristina Skert, MD, Carla Filì, MD, Maurizio Castelli, MD, Giovanni Martinelli, MD, Daniela Damiani, MD, Michele Baccarani, MD

Blood (2005) 106 (11): 4416.

https://doi.org/10.1182/blood.V106.11.4416.4416

Published: 2005

Journal Articles

Efficacy and Toxicity of FLAI vs ICE for Induction Treatment of Newly Diagnosed AML Patients, Younger Than 60 Years.

Blood (2004) 104 (11): 878.

https://doi.org/10.1182/blood.V104.11.878.878

Published: 2004

Journal Articles

Autologous transplantation of granulocyte colony-stimulating factor–primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization

Roberto M. Lemoli, Antonio de Vivo, Daniela Damiani, Alessandro Isidori, Monica Tani, Alessandro Bonini, Claudia Cellini, Antonio Curti, Luigi Gugliotta, Giuseppe Visani, Renato Fanin, Michele Baccarani

Blood (2003) 102 (5): 1595–1600.

https://doi.org/10.1182/blood-2003-02-0440

Published: 2003

Journal Articles

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

Francesco Zaja, Salvatore De Vita, Cesare Mazzaro, Stefania Sacco, Daniela Damiani, Ginevra De Marchi, Angela Michelutti, Michele Baccarani, Renato Fanin, Gianfranco Ferraccioli

Blood (2003) 101 (10): 3827–3834.

https://doi.org/10.1182/blood-2002-09-2856

Published: 2003

Journal Articles

Randomized Trial of Autologous Filgrastim-Primed Bone Marrow Transplantation Versus Filgrastim-Mobilized Peripheral Blood Stem Cell Transplantation in Lymphoma Patients

Daniela Damiani, Renato Fanin, Federico Silvestri, Stefania Grimaz, Laura Infanti, Antonella Geromin, Michela Cerno, Mariagrazia Michieli, Cristina Rinaldi, Chiara Savignano, Gabriella Trani, Mauro Fiacchini, Michele Baccarani

Blood (1997) 90 (1): 36–42.

https://doi.org/10.1182/blood.V90.1.36

Published: 1997

NARROW

Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study)

BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC"

ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients

Clinical Factors Predictive Of Myelofibrotic Evolutions In Patients With Essential Thrombocythemia and Polycythemia Vera

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

A Simple Clinical Prognostic Scoring System for Newly Diagnosed Cytogenetically Normal Acute Myeloid Leukemia: a Retrospective Analysis on 530 Patients

Q141K Polymorphism of ABCG2 Protein Is Associated with Poor Prognosis In Adult Acute Myeloid Leukemia Treated with a Idarubicin-Based Chemotherapy Protocol

Gemtuzumab-Ozogamicin in Combination with Fludarabine, Cytarabine, Idarubicin (FLAI-GO) as Induction Therapy in CD33-Positive AML patients Younger Than 65 Years. Report of a Multicentric Trial

Brain Natriuretic Peptide (BNP) Level as Marker of Cardiac Function in Imatinib - Treated Chronic Myeloid Leukemia Patients: No Evidence of Cardiotoxicity of Imatinib Therapy.

Fungal and Bacterial Infections in Acute Myeloid Leukemia Patients Treated with Induction Regimens Including Fludarabine: A Retrospective Analysis of 224 Cases.

Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow)

Fludarabine Based Regimen (FLAI) Is an Effective Treatment for Induction of Multidrug Resistant Pgp-Positive Acute Myeloid Leukemia Patients.

Antiproliferative Effects of Tyrosine Kinase (STI 571) and Farnesyl Transferase Inhibitors (R115777 and SCH66336) on Acute Leukemia Human Tumor Cell Lines.

Efficacy and Toxicity of FLAI vs ICE for Induction Treatment of Newly Diagnosed AML Patients, Younger Than 60 Years.

Autologous transplantation of granulocyte colony-stimulating factor–primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

Randomized Trial of Autologous Filgrastim-Primed Bone Marrow Transplantation Versus Filgrastim-Mobilized Peripheral Blood Stem Cell Transplantation in Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only